Patent details
EP2435459
Title:
UTILIZATION OF PHARMACOLOGICAL CHAPERONES TO IMPROVE MANUFACTURING AND PURIFICATION OF ACID BETA-GLUCOSIDASE
Basic Information
- Publication number:
- EP2435459
- PCT Application Number:
- PCT/US/2010/036225
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107811432
- PCT Publication Number:
- WO/2010/138608
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- UTILIZATION OF PHARMACOLOGICAL CHAPERONES TO IMPROVE MANUFACTURING AND PURIFICATION OF ACID BETA-GLUCOSIDASE
- French Title of Invention:
- UTILISATION DE CHAPERONS PHARMACOLOGIQUES POUR AMÉLIORER LA FABRICATION ET LA PURIFICATION DE BÊTA-GLUCOSIDASE ACIDE
- German Title of Invention:
- VERWENDUNG PHARMAKOLOGISCHER CHAPERONE ZUR VERBESSERTEN HERSTELLUNG UND REINIGUNG SAURER BETA-GLUCOSIDASE
- SPC Number:
-
Dates
- Filing date:
- 26/05/2010
- Grant date:
- 04/05/2016
- EP Publication Date:
- 04/05/2016
- PCT Publication Date:
- 02/12/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/04/2012
- EP B1 Publication Date:
- 04/05/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/05/2016
- Expiration date:
- 26/05/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/05/2010
-
-
- Name:
- Amicus Therapeutics Inc.
- Address:
- 1 Cedar Brook Drive, Cranbury, NJ 08512, United States (US)
Inventor
- Name:
- DO Hung, V.
- Address:
- United States (US)
Priority
- Priority Number:
- 181255 P
- Priority Date:
- 26/05/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C12N 9/96;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |